Counterfeit and substandard drugs

被引：16

作者：

Reidenberg, MM ^{[1
]}

Conner, BA ^{[1
]}

机构：

[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 04期

关键词：

D O I：

10.1067/mcp.2001.114672

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：189 / 193

页数：5

共 14 条

[1]

[Anonymous], 2004, QUALITY ASSURANCE PH, V2

[2] Internet availability of prescription pharmaceuticals to the public [J].

Bloom, BS ;

Iannacone, RC .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (11) :830-+

[3] Sao Paolo - Epidemic of counterfeit drugs causes concern in Brazil [J].

Csillag, C .

LANCET, 1998, 352 (9127) :553-553

[4]

*DEP ESS DRUGS OTH, 1999, COUNT DRUGS

[5]

Giminez F, 1997, MED MALADIES INFECT, V271, P541

[6]

LUECK S, 2000, WALL STREET J 0510

[7] Pharmaceutical products declared by US residents on returning to the United States from Mexico [J].

McKeithan, EK ;

Shepherd, MD .

CLINICAL THERAPEUTICS, 1996, 18 (06) :1242-1251

[8]

PETRALANDA I, 1995, LANCET, V345, P1437

[9]

POLE D, 1989, DRUG DISTRIBUTION FA

[10] Assessment of the incidence of substandard drugs in developing countries [J].

Shakoor, O ;

Taylor, RB ;

Behrens, RH .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (09) :839-845

← 1 2 →